The relationship between fibromyalgia and major depressive disorder: a comprehensive review

被引:46
作者
Pae, Chi-Un [1 ,2 ]
Luyten, Patrick [3 ]
Marks, David M. [2 ]
Han, Changsu [2 ,4 ]
Park, Sung-Hwan [5 ,6 ]
Patkar, Ashwin A. [2 ]
Masand, Prakash S. [2 ]
Van Houdenhove, Boudewijn [7 ]
机构
[1] Catholic Univ Korea, Coll Med, Kangnam St Marys Hosp, Dept Psychiat, Seoul 137701, South Korea
[2] Duke Univ, Med Ctr, Dept Psychiat & Behav Sci, Durham, NC USA
[3] Univ Louvain, Dept Psychol, Louvain, Belgium
[4] Korea Univ, Dept Psychiat, Seoul, South Korea
[5] Catholic Univ Korea, Coll Med, Kangnam St Marys Hosp, Ctr Rheumat Dis, Seoul 137701, South Korea
[6] Catholic Univ Korea, Coll Med, Rheumatism Res Ctr, Seoul 137701, South Korea
[7] Univ Hosp Leuven, Dept Liaison Psychiat, Louvain, Belgium
关键词
antidepressant; fibromyalgia; major depressive disorder; relationship;
D O I
10.1185/03007990802288338
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: A large body of evidence suggests that the relationship between major depressive disorder (MDD) and fibromyalgia (FM) is complex. Improved understanding of this relationship promises to provide clinicians with better assessment and treatment options for both disorders. Method: This paper reviews research on the prevalence, etiology and pathogenesis, clinical characterization, and treatment of FM and MOO, as well as studies that examined the relationship between these disorders. Studies were identified via PubMed literature search. Results: Our findings point to substantial similarities in neuroendocrine abnormalities, psychological characteristics, physical symptoms and treatments between FM and MOO. However, currently available findings do not support the assumption that MDD and FM refer to the same underlying construct or can be seen as subsidiaries of one disease concept. Conclusion: New methodological and theoretical approaches may lead to a better understanding of the link between FM and MOO, and to more effective psychological and psychopharmacological therapies for FM patients. In the meantime, clinicians should carefully screen for a history of MOD in patients with FM.
引用
收藏
页码:2359 / 2371
页数:13
相关论文
共 147 条
[21]  
Bazzichi L, 2007, CLIN EXP RHEUMATOL, V25, P225
[22]   Alteration of serotonin transporter density and activity in fibromyalgia [J].
Bazzichi, Laura ;
Giannaccini, Gino ;
Betti, Laura ;
Mascia, Giovanni ;
Fabbrini, Laura ;
Italiani, Paola ;
De Feo, Francesca ;
Giuliano, Tiziana ;
Giacomelli, Camillo ;
Rossi, Alessandra ;
Lucacchini, Antonio ;
Bombardieri, Stefano .
ARTHRITIS RESEARCH & THERAPY, 2006, 8 (04)
[23]   Evidence of qualitatively altered nociception in patients with fibromyalgia [J].
Bendtsen, L ;
Norregaard, J ;
Jensen, R ;
Olesen, J .
ARTHRITIS AND RHEUMATISM, 1997, 40 (01) :98-102
[24]  
BENNETT R, 2000, TXB PAIN
[25]   Emerging concepts in the neurobiology of chronic pain: Evidence of abnormal sensory processing in fibromyalgia [J].
Bennett, RM .
MAYO CLINIC PROCEEDINGS, 1999, 74 (04) :385-398
[26]  
Bennett RM, 1998, Z RHEUMATOL, V57, P72
[27]  
Bethea C L, 2000, Novartis Found Symp, V230, P112, DOI 10.1002/0470870818.ch9
[28]  
BIBOLOTTI E, 1986, CLIN TRIALS J, V23, P269
[29]   α1-Antitrypsin and fibromyalgia:: new data in favour of the inflammatory hypothesis of fibromyalgia [J].
Blanco, IE ;
de Serres, FJ ;
Fernandez-Bustillo, E ;
Al Kassam, D ;
Arbesú, D ;
Rodríguez, C ;
Torre, JC .
MEDICAL HYPOTHESES, 2005, 64 (04) :759-769
[30]  
Blier P, 2004, J PSYCHIATR NEUROSCI, V29, P208